Bionomics Limited Stock Retained Earnings
BNOEFDelisted Stock | USD 0.01 0.00 0.00% |
Bionomics Limited fundamentals help investors to digest information that contributes to Bionomics' financial success or failures. It also enables traders to predict the movement of Bionomics Pink Sheet. The fundamental analysis module provides a way to measure Bionomics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bionomics pink sheet.
Bionomics |
Bionomics Limited Company Retained Earnings Analysis
Bionomics' Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current Bionomics Retained Earnings | (103 M) |
Most of Bionomics' fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bionomics Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
CompetitionBased on the latest financial disclosure, Bionomics Limited has a Retained Earnings of (103 Million). This is 111.06% lower than that of the Healthcare sector and 206.3% lower than that of the Biotechnology industry. The retained earnings for all United States stocks is 101.1% higher than that of the company.
Did you try this?
Run Economic Indicators Now
Economic IndicatorsTop statistical indicators that provide insights into how an economy is performing |
All Next | Launch Module |
Bionomics Fundamentals
Return On Equity | -0.42 | |||
Return On Asset | -0.18 | |||
Operating Margin | (2.91) % | |||
Current Valuation | 27.83 M | |||
Shares Outstanding | 1.35 B | |||
Shares Owned By Insiders | 6.00 % | |||
Shares Owned By Institutions | 48.96 % | |||
Price To Earning | (34.09) X | |||
Price To Book | 1.24 X | |||
Price To Sales | 8.29 X | |||
Revenue | 263.63 K | |||
Gross Profit | (9.94 M) | |||
EBITDA | (21.92 M) | |||
Net Income | (21.76 M) | |||
Cash And Equivalents | 33.56 M | |||
Cash Per Share | 0.03 X | |||
Total Debt | 693.62 K | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 12.46 X | |||
Book Value Per Share | 0.04 X | |||
Cash Flow From Operations | (21.76 M) | |||
Earnings Per Share | (0.01) X | |||
Number Of Employees | 22 | |||
Beta | 2.18 | |||
Market Capitalization | 29.11 M | |||
Total Asset | 65.31 M | |||
Retained Earnings | (103 M) | |||
Working Capital | 47 M | |||
Current Asset | 58 M | |||
Current Liabilities | 11 M | |||
Z Score | 23.2 | |||
Net Asset | 65.31 M |
About Bionomics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bionomics Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bionomics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bionomics Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Bionomics Pink Sheet
If you are still planning to invest in Bionomics Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bionomics' history and understand the potential risks before investing.
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |